Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-05-10

FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for furosemide submitted by Hikma Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FUROSEMIDE (Furosemide)

Snippet

SUPPL AP for FUROSEMIDE (FUROSEMIDE)